Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mesogenin-1 (MSGN1) is a basic helix-loop-helix (bHLH) transcription factor critically required for the specification and differentiation of the paraxial mesoderm during embryonic development in vertebrates. MSGN1 is expressed specifically and transiently in the presomitic mesoderm, where it acts as a master regulatory switch activating the transcriptional programs necessary for paraxial mesoderm identity, segmentation (somite formation), cell movement, and epithelial-mesenchymal transition (EMT). MSGN1 induces key regulators such as Tbx6 as well as genes controlling EMT, Notch signaling, and planar cell polarity. It is directly downstream of canonical Wnt signaling and Tbx6, integrating developmental signals to drive trunk musculoskeletal fate and suppress alternate (neural) cell fates in bipotent stem cell populations. Gene knockouts in mice result in substantially diminished presomitic mesoderm and absence of somites along the trunk axis, with profound defects in musculoskeletal development. While MSGN1 does not currently represent a therapeutic target or disease biomarker, its essential position in embryonic patterning makes it a focus for basic developmental biology and regenerative medicine research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mesogenin-1 (MSGN1).